★ Is This the Therapy Big Medicine Tried to Bury?
★ TOP STORY
Is This the Therapy Big Medicine Tried to Bury?
It reversed deadly infections, calmed autoimmune attacks, and revived near-lifeless patients in hours - yet it was blacklisted, censored, and wiped from modern textbooks. Now it's making a quiet comeback.
Advertisement
Unlock Benefits Beyond Your Gut with Premium Probiotics
Gut health not only affects your digestive system but your immune, heart, and brain health as well. Our potent, multi-strain Complete Probiotics formula utilizes patented delayed-release capsules for protection against harsh stomach acids, delivering the 10 probiotic strains directly to your small intestine where they work best.
📈 TRENDING NEWS
Flexibility Gains Don't Take Hours - Just 2 Minutes
Discover how to transform your flexibility and eliminate back pain in just two minutes a day - without grueling stretches or complicated routines. These simple techniques focus on rewiring how your body moves, not just how far it stretches.
Napping Behaviors Predict Mortality Risk in Middle- to Older-Aged Adults
Think your afternoon nap is harmless? Research shows that the timing and length of your daytime rest could silently signal deeper health issues - and even predict your risk of early death.
🔥 HOT
Breaking News: What You Need to Know
Up-to-date info on the latest health-related news happening in the world.
Advertisement
Defend Your Heart and Bones with Patented K2
This powerful, exclusive bioactive form of vitamin K2 promotes your body's use of calcium and supports your arterial function. Take control of your cardiovascular health with our Vitamin K2, formulated with the patented form of MK-7, MenaQ7®, a highly bioactive and bioavailable form of vitamin K2, for optimal effectiveness.
Disclaimer: The entire contents of this website are based upon the opinions of Dr. Mercola, unless otherwise noted. Individual articles are based upon the opinions of the respective author, who retains copyright as marked. The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of Dr. Mercola and his community. Dr. Mercola encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional.
Mercola.com, 125 SW 3rd Place, Suite 205, Cape Coral, FL 33991
US Number: (877) 985-2695 | Intl Number: 1 (239) 599-9500
© 1997-2025 Dr. Joseph Mercola. All Rights Reserved.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Ultraviolet blood irradiation (UBI) was successfully used in the 1930s and 1940s for a variety of diseases. Despite this success, a lack of understanding of the detailed mechanisms of action and the achievements of antibiotics gradually reduced the use of UBI from the 1950s onward. The emergence of new viral infections, from HIV/AIDS to Ebola, from SARS and MERS to SARS-CoV-2, drew renewed attention to this therapeutic opportunity. UBI has a complex virucidal activity, acting primarily on the immune system response. It has effects on lymphocytes (T cells and B cells), macrophages, monocytes, dendritic cells, low-density lipoproteins (LDL), and lipids. Knott's technique has been applied to bacterial infections such as tuberculosis and viral infections such as hepatitis and influenza. The more complex extracorporeal photopheresis (ECP) is also being applied to hematologic cancers such as T-cell lymphomas.
https://link.springer.com/article/10.1007/s12016-020-08811-8 (2021).--
A CHRONOLOGICAL HISTORY OF UVBI By: Dr. Danilo Fernandez
https://gmtpci.com/wp-content/uploads/2021/01/1-CHRONOLOGICAL-HISTORY-OF-UVBI.pdf
This article describes an FDA Phase II clinical trial of ultraviolet blood irradiation (UVBI) in patients with hepatitis C virus (HCV) infection. The therapy was shown to be safe in this US FDA clinical trial. Two patients in the trial who had concurrent psoriasis showed a clinical response to this therapy. This device has also demonstrated efficacy in unpublished animal studies on influenza virus and simian immunodeficiency virus infection.
https://www.sciencedirect.com/science/article/pii/S120197121500140X (2015).--
Isn’t this what they ridiculed President Trump for?